Navigation Links
TorreyPines Therapeutics Reports Third Quarter 2007 Results
Date:11/14/2007

rch and development 8,161 4,470 20,390 17,640

General and administrative 1,351 680 4,209 1,986

Total operating expenses 9,512 5,150 24,599 19,626

Loss from operations (7,049) (2,687) (17,211) (12,238)

Other income (expense)

Interest income 504 259 1,699 732

Interest expense (193) (279) (647) (735)

Other income (expense), net (36) - 946 2

Total other income (expense) 275 (20) 1,998 (1)

Net loss (6,774) (2,707) (15,213) (12,239)

Dividends and accretion

to redemption value of

redeemable convertible

preferred stock - (1,237) - (3,534)

Net loss attributable

to common stockholders $(6,774) $(3,944) $(15,213) $(15,773)

Basic and diluted net

loss per share

attributable to common

stockholders* $(0.43) $(7.18) $(0.97) $(29.19)

Weighted average shares

used in the computation

of basic and diluted net

loss per share

attributable to

common stockholders *15,733,970 549,481 15,711,212 540,395

* Basic and diluted net loss per share attributable to common

stockholders and weighted average shares outstanding were impacted by

the conversion of preferred stock and issuance of common stock in

connection with the Axonyx merger.


'/>"/>
SOURCE TorreyPines Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. TorreyPines Therapeutics to Present at the NewsMakers in the Biotech Industry Conference
2. TorreyPines Therapeutics to Present at ThinkEquitys G5 Conference
3. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
4. TorreyPines Therapeutics to Present at ThinkEquitys ThinkClinic Conference
5. TorreyPines Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
10. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... July 11, 2014 Research and Markets ... Technology Market - Global Industry Analysis, Size, Share, Growth, ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... acids (either DNA or RNA) into cells. This technology ... cancer cells and protein metabolism by affecting the nuclear ...
(Date:7/11/2014)... 2014  Researchers have pioneered a revolutionary new ... technology, called Virtual Finger, allows scientists to move ... and synapses using the flat surface of their ... imaging studies orders of magnitude more efficient, saving ... across many areas of experimental biology. The software ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 Deep ... Century Medicine Forum on ‘Commercialising Longevity Research’ and ... entrepreneurs to the London Bioscience Innovation Center for ... Foundation and Aging Analytics Ltd. The meeting highlighted ... in translational research for age-related disease, as well ...
(Date:7/10/2014)... Poway, CA (PRWEB) July 10, 2014 Robert ... Regenerative Veterinary Medicine company, is proud to announce the relaunch ... Pets, launching with a new series called “ What are ... to give an honest and straightforward foundation in the basics ... an educated decision on the right type of treatment when ...
Breaking Biology Technology:International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 5DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 6Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3
... 11 Replikins Ltd. today announced its,latest findings ... influenza,virus. The company,s software-driven analysis has found that ... Indonesia; in addition, higher,counts now have been found ... gene which has been linked to the lethality ...
... in Inventory Management, Disposables ... WESTMINSTER, Colo., Dec. 11 , WHAT: This presentation identifies key challenges ... and supplies and explains how embedded RFID ... that enhances safety and reliability, ...
... Belgium, December 11 , - TB-402 Shows ... Prevention of Thromboembolic Disorders., ThromboGenics NV (Euronext ... disease, announced that the results of the,first Phase ... the prestigious,American Society of Hematology (ASH) 49th Annual ...
Cached Biology Technology:Lethal Human H5N1 Influenza Virus Replikin Gene Still Upregulated 2SkyeTek to Present Webinar on Transforming the Management of Medical Devices & Supplies with Embedded RFID 2ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting 2ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting 3ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting 4
(Date:7/11/2014)... SEATTLE, WASH. July 11, 2014 Researchers ... navigate three-dimensional images. The new technology, called Virtual ... of small structures like neurons and synapses using ... Finger,s unique technology makes 3D imaging studies orders ... resources at an unprecedented level across many areas ...
(Date:7/11/2014)... In addition to the hippocampus, the marginal division ... and memory. What is the impact degree of ... learning and memory function? Yan Yu and his ... China found, using immunofluorescence staining, that substance P ... hippocampus and striatal marginal division of normal rats. ...
(Date:7/11/2014)... -- Research and Markets has announced the ... Industry Analysis Size Share Growth Trends and Forecast to ... http://photos.prnewswire.com/prnh/20130307/600769 The rising number ... for high level security in both private and public ... username and passwords, tokens etc. are vulnerable to attacks. ...
Breaking Biology News(10 mins):Virtual finger enables scientists to navigate and analyze complex 3D images 2International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2
... PA -- Scientists may have made an "a-maize-ing" ... the United States. In a new research report published ... Genetics ( http://www.genetics.org ), scientists used tropical maize ... for detecting seasonal changes in flowering time (called the ...
... only. New Cornell University evolutionary biology research shows how ... evolved mechanisms that influence ecosystem dynamics as well. ( ... interactions of most organisms is dictated by their evolutionary ... evolutionary biology (EEB), the study,s senior author. In ...
... , This release is available in Spanish ... for Agricultural Research and Development (Neiker-Tecnalia) has questioned the generally ... their exposure to natural light and states that the most ... the Institute,s Department of Agricultural Production and Protection and opens ...
Cached Biology News:'A-maize-ing' discovery could lead to higher corn yields for food, feed and fuel 2Move over predators: Plants can control the food chain too -- from the bottom up 2The quality of the tomato depends more on temperature than on natural light 2
... iTaq DNA polymerase is ... suitable for both conventional and ... is supplied at a concentration ... and includes 5,000 units polymerase, ...
... the formation of a phosphodiester bonds between ... duplex DNA molecules or between oligonucleotides which ... at 45 - 65?. Tfi DNA Ligase ... temperatures than conventional DNA ligases, Thus, Tfi ...
... contains a unique β-agarose digesting enzyme developed ... intact DNA and RNA from low melting ... TAE, TBE, MOPS, or phosphate buffers. The ... TAE, TBE, MOPS, and phosphate electrophoresis buffers ...
... in-house demand is causing shortages in your ... This can cause unwanted distractions, problems and ... royalties for your hard work and endeavour! ... build it up,and market it internationally. We ...
Biology Products: